Would Canada-EU Trade Proposals Add $2.8 Billion Price Tag To Drugs Bill?
A study by the Canadian Generic Pharmaceuticals Association (CGPA) suggests that the European Union’s (EU) proposed changes to Canada’s patent system could add nearly $3 billion to Canada’s prescription drug bill.
